These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7754928)

  • 21. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of endomyometritis.
    Yonekura ML
    J Reprod Med; 1988 Jun; 33(6 Suppl):579-83. PubMed ID: 3260948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of penetrating abdominal trauma and gynecologic infections.
    Levine DP; Wilson RF
    J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M; Ito T
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic therapy of intra-abdominal sepsis in the elderly: experience with ticarcillin and clavulanic acid.
    Fink MP
    Surg Gynecol Obstet; 1991; 172 Suppl():36-41. PubMed ID: 2024225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
    Uzuka Y; Matsumoto K
    Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV; Aldridge KE
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM; Hope R; Mushtaq S; Warner M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms.
    McGregor JA; Christiansen FB
    J Reprod Med; 1988 Jun; 33(6 Suppl):591-4. PubMed ID: 3294404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience.
    Wilson SE; Nord CE
    Am J Surg; 1995 May; 169(5A Suppl):21S-26S. PubMed ID: 7755164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
    Klepser ME; Marangos MN; Zhu Z; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
    Dolapçi I
    Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
    Powell LL; Wilson SE
    Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-lactam/beta-lactamase inhibitor combinations for oral administration].
    Franciolli M
    Schweiz Med Wochenschr; 1991 Sep; 121(39):1399-407. PubMed ID: 1925470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A; Räder K
    Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.